King Bio Recalls LymePlex Due to Microbial Contamination
King Bio Inc. is recalling Dr. King's SafeCare Rx LymePlex due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 per the rubric.
Plain-English summary
King Bio Inc. is voluntarily recalling 95 bottles of Dr. King's SafeCare Rx LymePlex, 2 fl. oz. (59 mL), due to microbial contamination. The product is identified by NDC 57955-0069-2 and UPC 357955006923.
The affected lots are 072815F (Exp. 07/18), 061716C (Exp. 06/19), 020817D (Exp. 02/20), and 030518F (Exp. 03/20). The product was distributed nationwide in the U.S.A., as well as in Canada and Australia.
Consumers should stop using the product and contact King Bio Inc. for further instructions or a refund.
The recalled product
- Product
- Dr. King's SafeCare Rx LymePlex, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955006923, NDC 57955-0069-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — Biological / Supplement
- Hazard
- Affected units
- 95
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots: 072815F Exp. 07/18
- 061716C Exp. 06/19
- 020817D Exp. 02/20
- 030518F Exp. 03/20
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- SevereMedtronic Recalls Grafton DBM Allografts Due to Donor Microbial Presence
FDA (Devices) · 2026-10-21
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereRed Mountain Compounding Recalls S-Lysine HCL Vials Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereRXQ Compounding Recalls Phenylephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- ModerateBioLyte Recalls NeoRelief Topical Gel Due to Ingredient Contamination
FDA (Drugs) · 2018-10-10
- SevereRed Mountain Compounding Recalls S-Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- HighInjectable Drug Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-04-27
- ModerateHealthmaxx Global Recalls MAX LIVER STRONG Capsules Due to Mislabeling
FDA (Food) · 2013-10-02